Top Back to top

Allogeneic HSCT in ICU setting

Severe Aplastic Anaemia Working Party (SAAWP)
Study type:
Study number:
84090093
Type of Stem Cell Treatment:
Allogeneic
Diseases:
Bone marrow failure
Short title:
Allo HCT in ICU
Primary objective:
Collect all – successful and unsuccessful – cases of allogeneic stem cell transplantation performed in patients requiring specialized ICU care, e.g. on ventilator (invasive and non-invasive) or even ECMO support during conditioning and at transplantation and evaluate the experience.
Key inclusion criteria:
 
Country:
All EBMT member countries
Principal investigator:
Tayfun Güngör
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email:
saawpebmt@lumc.nl
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys

Privacy notices

Article 6 lawful basis for processing personal data:
Not applicable to surveys
Article 9 basis for processing special category data:
Not applicable to surveys

Data Protection Impact Assessments

Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys